JNJ

JOHNSON & JOHNSON

US StockNYSEPharmaceutical Preparations

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

94.2B USDAnnual · FY 2025

Operating income

21.6B USDAnnual · FY 2014

Net income

26.8B USDAnnual · FY 2025

Total assets

199.2B USDAnnual · FY 2025

Equity

81.5B USDAnnual · FY 2025

Operating cash flow

24.5B USDAnnual · FY 2025

JNJ · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

94.2B USD

Period data
PeriodValue
FY 202178.7B USD
FY 202280B USD
FY 202385.2B USD
FY 202488.8B USD
FY 202594.2B USD

Operating income

USD

21.6B USD

Period data
PeriodValue
FY 201017.7B USD
FY 201113.8B USD
FY 201215B USD
FY 201316.4B USD
FY 201421.6B USD

Net income

USD

26.8B USD

Period data
PeriodValue
FY 202120.9B USD
FY 202217.9B USD
FY 202335.2B USD
FY 202414.1B USD
FY 202526.8B USD

Total assets

USD

199.2B USD

Period data
PeriodValue
FY 2021182B USD
FY 2022187.4B USD
FY 2023167.6B USD
FY 2024180.1B USD
FY 2025199.2B USD

Equity

USD

81.5B USD

Period data
PeriodValue
FY 202174B USD
FY 202276.8B USD
FY 202368.8B USD
FY 202471.5B USD
FY 202581.5B USD

Operating cash flow

USD

24.5B USD

Period data
PeriodValue
FY 202123.4B USD
FY 202221.2B USD
FY 202322.8B USD
FY 202424.3B USD
FY 202524.5B USD

Revenue growth

%

6%

Period data
PeriodValue
FY 2021-4.7%
FY 20221.6%
FY 20236.5%
FY 20244.3%
FY 20256%

Operating income growth

%

31.6%

Period data
PeriodValue
FY 20106.7%
FY 2011-22.2%
FY 20128.6%
FY 20139.7%
FY 201431.6%

Net income growth

%

90.6%

Period data
PeriodValue
FY 202141.9%
FY 2022-14.1%
FY 202395.9%
FY 2024-60%
FY 202590.6%

Operating margin

%

No applicable data available

No applicable data available

Net margin

%

28.5%

Period data
PeriodValue
FY 202126.5%
FY 202222.4%
FY 202341.3%
FY 202415.8%
FY 202528.5%

Return on assets

%

14.1%

Period data
PeriodValue
FY 202111.7%
FY 20229.7%
FY 202319.8%
FY 20248.1%
FY 202514.1%

Debt/Equity

x

1.44x

Period data
PeriodValue
FY 20211.46x
FY 20221.44x
FY 20231.44x
FY 20241.52x
FY 20251.44x